196 related articles for article (PubMed ID: 2476814)
41. Synthesis and biological activities of oligo(8-bromoadenylates) as analogues of 5'-O-triphosphoadenylyl(2'----5')adenylyl(2'----5')adenosine.
Lesiak K; Torrence PF
J Med Chem; 1986 Jun; 29(6):1015-22. PubMed ID: 3712372
[TBL] [Abstract][Full Text] [Related]
42. 2',5'-Oligoadenylate trimer core and the cordycepin analog augment the tumoricidal activity of human natural killer cells.
Black PL; Henderson EE; Pfleiderer W; Charubala R; Suhadolnik RJ
J Immunol; 1984 Nov; 133(5):2773-7. PubMed ID: 6332860
[TBL] [Abstract][Full Text] [Related]
43. Antiviral amphipathic oligo- and polyribonucleotides: analogue development and biological studies.
Hyde RM; Broom AD; Buckheit RW
J Med Chem; 2003 May; 46(10):1878-85. PubMed ID: 12723951
[TBL] [Abstract][Full Text] [Related]
44. Effect of interferon and 2',5'-oligoadenylates on rotavirus RNA synthesis.
Ríos M; Muñoz M; Torrence PF; Spencer E
Antiviral Res; 1995 Mar; 26(2):133-43. PubMed ID: 7605112
[TBL] [Abstract][Full Text] [Related]
45. 2',5'-Oligoadenylates chiral at phosphorus: enzymatic synthesis, properties, and biological activities of 2',5'-phosphorothioate trimer and tetramer analogues synthesized from (SP)-ATP alpha S.
Lee C; Suhadolnik RJ
Biochemistry; 1985 Jan; 24(3):551-5. PubMed ID: 3994975
[TBL] [Abstract][Full Text] [Related]
46. Synthesis, characterization, and biological properties of 8-azido- and 8-amino-substituted 2',5'-oligoadenylates.
Sawai H; Hirano A; Mori H; Shinozuka K; Dong B; Silverman RH
J Med Chem; 2003 Nov; 46(23):4926-32. PubMed ID: 14584943
[TBL] [Abstract][Full Text] [Related]
47. High yield synthesis, purification and characterisation of the RNase L activators 5'-triphosphate 2'-5'-oligoadenylates.
Morin B; Rabah N; Boretto-Soler J; Tolou H; Alvarez K; Canard B
Antiviral Res; 2010 Sep; 87(3):345-52. PubMed ID: 20547186
[TBL] [Abstract][Full Text] [Related]
48. Analogue inhibitor of 2-5A action: effect on the interferon-mediated inhibition of encephalomyocarditis virus replication.
Watling D; Serafinowska HT; Reese CB; Kerr IM
EMBO J; 1985 Feb; 4(2):431-6. PubMed ID: 2410258
[TBL] [Abstract][Full Text] [Related]
49. Synthesis of alpha-anomeric homopyrimidine oligo DNA phosphorothioates and their physicochemical and biochemical properties.
Shinozuka K; Yamada N; Sawai H
Nucleic Acids Symp Ser; 1995; (34):121-2. PubMed ID: 8841582
[TBL] [Abstract][Full Text] [Related]
50. Core (2'-5')oligoadenylate and the cordycepin analog: inhibitors of Epstein--Barr virus-induced transformation of human lymphocytes in the absence of interferon.
Doetsch PW; Suhadolnik RJ; Sawada Y; Mosca JD; Flick MB; Reichenbach NL; Dang AQ; Wu JM; Charubala R; Pfleiderer W; Henderson EE
Proc Natl Acad Sci U S A; 1981 Nov; 78(11):6699-703. PubMed ID: 6171822
[TBL] [Abstract][Full Text] [Related]
51. Stereoconfiguration markedly affects the biochemical and biological properties of phosphorothioate analogs of 2-5A core, (A2'p5')2A.
Eppstein DA; Schryver BB; Marsh YV
J Biol Chem; 1986 May; 261(13):5999-6003. PubMed ID: 3009440
[TBL] [Abstract][Full Text] [Related]
52. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.
Matsukura M; Shinozuka K; Zon G; Mitsuya H; Reitz M; Cohen JS; Broder S
Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7706-10. PubMed ID: 3499613
[TBL] [Abstract][Full Text] [Related]
53. Antiviral effects of 2',5'oligoadenylates (2-5As), and related compounds.
Tominaga A; Saito S; Kohno S; Sakurai K; Hayakawa Y; Noyori R
Microbiol Immunol; 1990; 34(9):737-47. PubMed ID: 2178211
[TBL] [Abstract][Full Text] [Related]
54. Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription.
Boulmé F; Freund F; Moreau S; Nielsen PE; Gryaznov S; Toulmé JJ; Litvak S
Nucleic Acids Res; 1998 Dec; 26(23):5492-500. PubMed ID: 9826777
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and anti-human immunodeficiency virus (HIV-1) activity of 3'-deoxy-3'-(triazol-1-yl)thymidines and 2',3'-dideoxy-3'-(triazol-1-yl)uridines and inhibition of reverse transcriptase by their 5'-triphosphates.
Hirota K; Hosono H; Kitade Y; Maki Y; Chu CK; Schinazi RF; Nakane H; Ono K
Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2597-601. PubMed ID: 1704819
[TBL] [Abstract][Full Text] [Related]
56. A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.
Malathi K; Paranjape JM; Bulanova E; Shim M; Guenther-Johnson JM; Faber PW; Eling TE; Williams BR; Silverman RH
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14533-8. PubMed ID: 16203993
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and biological activity of tubercidin analogues of ppp5'A2'p(5'A2'p)n5'A.
Jamoulle JC; Imai J; Lesiak K; Torrence PF
Biochemistry; 1984 Jun; 23(13):3063-9. PubMed ID: 6466631
[TBL] [Abstract][Full Text] [Related]
58. Caspase-dependent apoptosis by 2',5'-oligoadenylate activation of RNase L is enhanced by IFN-beta.
Rusch L; Zhou A; Silverman RH
J Interferon Cytokine Res; 2000 Dec; 20(12):1091-100. PubMed ID: 11152576
[TBL] [Abstract][Full Text] [Related]
59. Chemical synthesis and biological characterization of phosphorothioate analogs of 2', 5'-3'-deoxyadenylate trimer.
Sobol RW; Charubala R; Pfleiderer W; Suhadolnik RJ
Nucleic Acids Res; 1993 May; 21(10):2437-43. PubMed ID: 7685081
[TBL] [Abstract][Full Text] [Related]
60. A new and potent 2-5A analogue which does not require a 5'-polyphosphate to activate mouse L-cell RNase L.
Torrence PF; Brozda D; Alster DK; Pabuccuoglu A; Lesiak K
Antiviral Res; 1992 Jun; 18(3-4):275-89. PubMed ID: 1416909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
